{
  "openalex_id": "W2261228095",
  "doi": "https://doi.org/10.18632/oncotarget.7208",
  "title": "miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial",
  "abstract": "// Khurum Khan 1 , David Cunningham 1 , Clare Peckitt 1 , Sarah Barton 1 , Diana Tait 1 , Maria Hawkins 1,2 , David Watkins 1 , Naureen Starling 1 , Sheela Rao 1 , Ruwaida Begum 1 , Janet Thomas 1 , Jacqui Oates 1 , Vincenza Guzzardo 3 , Matteo Fassan 3 , Chiara Braconi 1,4 and Ian Chau 1 1 Gastrointestinal Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK 2 CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Oxford, UK 3 Department of Medicine, University of Padua, Padua, IT 4 Division of Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK Correspondence to: Chiara Braconi, email: // Ian Chau, email: // Keywords : pancreatic cancer, microRNA, miR-21, chemo-radiotherapy, cetuximab Received : November 27, 2015 Accepted : January 25, 2016 Published : February 05, 2016 Abstract Background: Locally advanced pancreatic cancer (LAPC) is associated with high mortality, and biomarker-driven treatment approach is currently lacking. This study evaluated safety and efficacy of a combination approach of chemotherapy followed by chemo-radiotherapy (CRT) +/- cetuximab, and the prognostic role of miR-21 in patients with LAPC treated with a multimodality approach. Patients and Methods: This was a randomised phase II trial in which patients with inoperable LAPC were offered gemcitabine and capecitabine (GEM-CAP) for 16 weeks. Patients with stable disease or response after GEM-CAP were randomised to capecitabine or UFT plus radiotherapy (RT) (A), or capecitabine or UFT plus cetuximab plus RT (B). The primary outcome of the study was overall survival (OS). Clinical outcome was compared according to baseline circulating miR-21 levels. Results: 17 patients were enrolled and treated with GEM-CAP, with 13 patients achieving disease control and being randomised to arms A (n:7) and B (n:6). After a median follow-up of 61.2 months, median progression free survival (PFS) was 10.4 months and 12.7 months, median OS was 15.8 months and 22.0 months in arms A and B respectively ( p > 0.05). Patients with high baseline plasma miR-21 had worse PFS (3.5 vs . 12.7 months; p:0.032) and OS (5.1 vs 15.3 months; p:0.5) compared to patients with low miR-21. Circulating miR-21 levels reflected miR-21 expression within the tissues. Conclusions: Addition of Cetuximab to CRT following induction chemotherapy did not improve survival. High miR-21 baseline plasma expression was associated with poor clinical outcome in LAPC patients treated with induction chemotherapy followed by chemo-radiotherapy.",
  "authors": [
    {
      "display_name": "Khurum Khan",
      "id": "A5071341853",
      "orcid": "https://orcid.org/0000-0001-9364-6182",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Khurum Khan"
    },
    {
      "display_name": "David Cunningham",
      "id": "A5056345420",
      "orcid": "https://orcid.org/0000-0001-5158-1069",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Cunningham"
    },
    {
      "display_name": "Clare Peckitt",
      "id": "A5057249944",
      "orcid": "https://orcid.org/0000-0001-6343-8462",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Clare Peckitt"
    },
    {
      "display_name": "Sarah Barton",
      "id": "A5110265166",
      "orcid": null,
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Sarah Barton"
    },
    {
      "display_name": "Diana Tait",
      "id": "A5112264494",
      "orcid": null,
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Diana Tait"
    },
    {
      "display_name": "M. Hawkins",
      "id": "A5023081058",
      "orcid": "https://orcid.org/0000-0002-6669-0628",
      "institutions": [
        {
          "id": "I40120149",
          "display_name": "University of Oxford",
          "country_code": "GB",
          "type": "funder"
        },
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I4210106471",
          "display_name": "CRUK/MRC Oxford Institute for Radiation Oncology",
          "country_code": "GB",
          "type": "facility"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Maria Hawkins"
    },
    {
      "display_name": "David Watkins",
      "id": "A5077300810",
      "orcid": "https://orcid.org/0000-0003-0212-1765",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Watkins"
    },
    {
      "display_name": "Naureen Starling",
      "id": "A5004047300",
      "orcid": "https://orcid.org/0000-0002-1496-6792",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Naureen Starling"
    },
    {
      "display_name": "Sheela Rao",
      "id": "A5101669770",
      "orcid": "https://orcid.org/0000-0003-1127-9919",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Sheela Rao"
    },
    {
      "display_name": "Ruwaida Begum",
      "id": "A5086258366",
      "orcid": "https://orcid.org/0009-0009-1825-351X",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ruwaida Begum"
    },
    {
      "display_name": "Janet Thomas",
      "id": "A5001977752",
      "orcid": null,
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Janet Thomas"
    },
    {
      "display_name": "Jacqui Oates",
      "id": "A5105362607",
      "orcid": null,
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jacqui Oates"
    },
    {
      "display_name": "Vincenza Guzzardo",
      "id": "A5110131979",
      "orcid": null,
      "institutions": [
        {
          "id": "I138689650",
          "display_name": "University of Padua",
          "country_code": "IT",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Vincenza Guzzardo"
    },
    {
      "display_name": "Matteo Fassan",
      "id": "A5046301295",
      "orcid": "https://orcid.org/0000-0001-6515-5482",
      "institutions": [
        {
          "id": "I138689650",
          "display_name": "University of Padua",
          "country_code": "IT",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Matteo Fassan"
    },
    {
      "display_name": "Chiara Braconi",
      "id": "A5047404111",
      "orcid": "https://orcid.org/0000-0003-4835-1259",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I142947616",
          "display_name": "Institute of Cancer Research",
          "country_code": "GB",
          "type": "education"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Chiara Braconi"
    },
    {
      "display_name": "Ian Chau",
      "id": "A5025120810",
      "orcid": "https://orcid.org/0000-0003-0286-8703",
      "institutions": [
        {
          "id": "I1325846038",
          "display_name": "Royal Marsden NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ian Chau"
    }
  ],
  "publication_year": 2016,
  "publication_date": "2016-02-05",
  "type": "article",
  "cited_by_count": 42,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "7",
  "issue": "11",
  "first_page": "12672",
  "last_page": "12681",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "https://www.oncotarget.com/article/7208/pdf/",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.87013954
    },
    {
      "id": "C2777909004",
      "display_name": "Capecitabine",
      "level": 4,
      "score": 0.84622574
    },
    {
      "id": "C2779998722",
      "display_name": "Cetuximab",
      "level": 4,
      "score": 0.84525573
    },
    {
      "id": "C2780258809",
      "display_name": "Gemcitabine",
      "level": 3,
      "score": 0.7490022
    },
    {
      "id": "C2780210213",
      "display_name": "Pancreatic cancer",
      "level": 3,
      "score": 0.6620953
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.64793396
    },
    {
      "id": "C509974204",
      "display_name": "Radiation therapy",
      "level": 2,
      "score": 0.6473616
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.6168993
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.5721203
    },
    {
      "id": "C526805850",
      "display_name": "Colorectal cancer",
      "level": 3,
      "score": 0.41822764
    }
  ],
  "topics": [
    {
      "id": "T10231",
      "display_name": "Pancreatic and Hepatic Oncology Research",
      "score": 1.0
    },
    {
      "id": "T11364",
      "display_name": "Cholangiocarcinoma and Gallbladder Cancer Studies",
      "score": 0.9952
    },
    {
      "id": "T10062",
      "display_name": "MicroRNA in disease regulation",
      "score": 0.9892
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.7208",
  "pdf_url": "https://www.oncotarget.com/article/7208/pdf/",
  "retrieved_date": "2025-07-30T14:56:46.652148",
  "source_database": "OpenAlex"
}